This activity is designed to provide primary care physicians and other members of the healthcare team an update on current issues in the care of cancer patients. This activity will provide information on cancer screening, treatment, and shared care management
This activity has been designed for primary care physicians including: general medicine, internal medicine, family practice, primary care practice nurses, and other healthcare professionals involved in the primary care of patients
At the completion of this course, participants should be able to:
- Identify new advances in cancer treatment including: immunotherapy, precision surgery, and proton therapy
- Describe the latest evidenced based screening guidelines for high incidence cancers
- Identify the role of the PCP in follow-up care and managing symptoms related to cancer and its treatment
In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Designation Of Credits
- PHYSICIANS: Penn Medicine designates this live activity for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- PHYSICIAN ASSISTANTS: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 2.25 Category 1 credits for completing this activity.
Penn Medicine, Office of Continuing Medical and Interprofessional Education, adheres to the ACCME Standards for Commercial Support. Faculty disclosure information will be made available in the conference materials and syllabus. Faculty members are also expected to disclose to participants any discussion of off-label and / or investigational use of pharmaceutical products or devices within their presentations.